首页 > 最新文献

Oncology Research and Treatment最新文献

英文 中文
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023. 欧洲肿瘤内科学会 2023 年年会的胃食管肿瘤学亮点。
IF 2 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-13 DOI: 10.1159/000538324
Magdalena K Scheck, Ira Ekmekciu, Greta Sommerhäuser, Christian Heise, Ilektra Antonia Mavroeidi, Volker Kunzmann, Henning Wege, Anke Reinacher-Schick, Ralf-Dieter Hofheinz, Thorsten Oliver Götze, Sylvie Lorenzen, Alexander Edward Nieto
{"title":"Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.","authors":"Magdalena K Scheck, Ira Ekmekciu, Greta Sommerhäuser, Christian Heise, Ilektra Antonia Mavroeidi, Volker Kunzmann, Henning Wege, Anke Reinacher-Schick, Ralf-Dieter Hofheinz, Thorsten Oliver Götze, Sylvie Lorenzen, Alexander Edward Nieto","doi":"10.1159/000538324","DOIUrl":"10.1159/000538324","url":null,"abstract":"","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140120228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study. 接受姑息治疗的晚期癌症门诊患者临终关怀意愿的稳定性和性别特征。前瞻性观察研究。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-03-01 DOI: 10.1159/000538112
Thomas Golombek, Nora Hegewald, Astrid Schnabel, Hansjakob Fries, Florian Lordick

Introduction: Early integration of palliative care and advance care planning (ACP) play an increasingly important role in the treatment of patients with advanced cancer. Advance directives (ADs) and patients' preferences regarding end-of-life (EoL) care are important aspects of ACP. In the outpatient setting, the prevalence of those documents and EoL care wishes is not well investigated, and changes in the longitudinal course are poorly understood.

Methods: From June 2020 to August 2022, 67 outpatients with advanced solid tumors undergoing palliative cancer therapy were interviewed on the topic of ACP in a longitudinal course. From this database, the prevalence of ADs, healthcare proxy, EoL care wishes, and the need for counseling regarding these issues were collected. In addition, EoL care wishes were examined for their stability.

Results: Fifty-one patients (76.1%) reported having ADs, and 41 patients (61.2%) reported having a healthcare proxy. Nineteen patients (37.3%) with ADs and 11 patients (68.7%) without ADs indicated a wish for counseling. Reported EoL care wishes remained stable over a period of approximately 6 months. Nevertheless, intraindividual changes occurred over time within the different EoL care preferences. The desire for resuscitation and dialysis were significantly higher in men than in women (resuscitation: 15 of 21 men [71.4%] versus 9 of 22 women [40.9%], odds ratio [OR] 3.611, 95% confidence interval [CI], 1.01-12.89, p = 0.048; dialysis: 16 of the 23 men [69.6%] versus 9 of the 25 women [36.0%], OR: 4.063, 95% CI: 1.22-13.58, p = 0.023).

Conclusion: Our results show a reasonably high percentage of ADs and healthcare proxies in our study cohort. The observed stability of EoL requests encourages the implementation of structured queries for ADs and healthcare proxy for outpatients undergoing palliative treatment. Our data suggest that gender-specific characteristics should be further investigated in this context.

简介在晚期癌症患者的治疗过程中,早期整合姑息关怀和预先护理计划(ACP)发挥着越来越重要的作用。预先医疗指示(AD)和患者对生命末期(EoL)护理的偏好是 ACP 的重要方面。在门诊环境中,这些文件和临终关怀意愿的普遍性没有得到很好的调查,纵向过程中的变化也不甚了解:方法:从 2020 年 6 月到 2022 年 8 月,对 67 名接受癌症姑息治疗的晚期实体瘤门诊患者进行了关于 ACP 主题的纵向访谈。从该数据库中收集了AD的患病率、医疗保健代理、EoL护理意愿以及就这些问题进行咨询的需求。此外,还对患者的 EoL 护理意愿的稳定性进行了研究:51名患者(76.1%)报告患有注意力缺失症,41名患者(61.2%)报告有医疗代理。19名(37.3%)有注意力缺失症的患者和 11 名(68.7%)无注意力缺失症的患者表示希望获得心理咨询。在大约 6 个月的时间里,所报告的 EoL 护理愿望保持稳定。然而,随着时间的推移,在不同的起居护理偏好中,个体内部也发生了变化。男性对复苏和透析的愿望明显高于女性(复苏:21 位男性中有 15 位(71.4%)希望进行透析;透析:21 位男性中有 15 位(71.4%)希望进行复苏):21名男性中的15人(71.4%)与22名女性中的9人(40.9%)相比,几率比[OR]为3.611,95%置信区间[CI]为1.01至12.89,P=0.048;透析:23名男性中的16人(69.6%)与25名女性中的9人(36.0%)相比,OR为4.063,95%置信区间[CI]为1.22至13.58,P=0.023):我们的研究结果表明,在我们的研究队列中,AD 和医疗保健代理的比例相当高。观察到的EoL请求的稳定性鼓励对接受姑息治疗的门诊患者进行AD和医疗代理的结构化查询。我们的数据表明,在这种情况下应进一步调查性别特征。
{"title":"Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study.","authors":"Thomas Golombek, Nora Hegewald, Astrid Schnabel, Hansjakob Fries, Florian Lordick","doi":"10.1159/000538112","DOIUrl":"10.1159/000538112","url":null,"abstract":"<p><strong>Introduction: </strong>Early integration of palliative care and advance care planning (ACP) play an increasingly important role in the treatment of patients with advanced cancer. Advance directives (ADs) and patients' preferences regarding end-of-life (EoL) care are important aspects of ACP. In the outpatient setting, the prevalence of those documents and EoL care wishes is not well investigated, and changes in the longitudinal course are poorly understood.</p><p><strong>Methods: </strong>From June 2020 to August 2022, 67 outpatients with advanced solid tumors undergoing palliative cancer therapy were interviewed on the topic of ACP in a longitudinal course. From this database, the prevalence of ADs, healthcare proxy, EoL care wishes, and the need for counseling regarding these issues were collected. In addition, EoL care wishes were examined for their stability.</p><p><strong>Results: </strong>Fifty-one patients (76.1%) reported having ADs, and 41 patients (61.2%) reported having a healthcare proxy. Nineteen patients (37.3%) with ADs and 11 patients (68.7%) without ADs indicated a wish for counseling. Reported EoL care wishes remained stable over a period of approximately 6 months. Nevertheless, intraindividual changes occurred over time within the different EoL care preferences. The desire for resuscitation and dialysis were significantly higher in men than in women (resuscitation: 15 of 21 men [71.4%] versus 9 of 22 women [40.9%], odds ratio [OR] 3.611, 95% confidence interval [CI], 1.01-12.89, p = 0.048; dialysis: 16 of the 23 men [69.6%] versus 9 of the 25 women [36.0%], OR: 4.063, 95% CI: 1.22-13.58, p = 0.023).</p><p><strong>Conclusion: </strong>Our results show a reasonably high percentage of ADs and healthcare proxies in our study cohort. The observed stability of EoL requests encourages the implementation of structured queries for ADs and healthcare proxy for outpatients undergoing palliative treatment. Our data suggest that gender-specific characteristics should be further investigated in this context.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11078325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Patients Undergoing CAR-T Cell Therapy in Germany. 德国 CAR-T 细胞疗法患者的管理。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-01-10 DOI: 10.1159/000536201
Olaf Penack, Peter Dreger, Salem Ajib, Francis Ayuk, Ben-Niklas Baermann, Gesine Bug, Oliver Kriege, Madlen Jentzsch, Guido Kobbe, Christian Koenecke, Mathias Lutz, Sonja Martin, Paul-Gerhard Schlegel, Roland Schroers, Bastian von Tresckow, Vladan Vucinic, Marion Subklewe, Wolfgang Bethge, Daniel Wolff

Introduction: Chimeric antigen receptor positive T cell (CAR-T cell) treatment became standard therapy for relapsed or refractory hematologic malignancies, such as non-Hodgkin's lymphoma and multiple myeloma. Owing to the rapidly progressing field of CAR-T cell therapy and the lack of generally accepted treatment guidelines, we hypothesized significant differences between centers in the prevention, diagnosis, and management of short- and long-term complications.

Methods: To capture the current CAR-T cell management among German centers to determine the medical need and specific areas for future clinical research, the DAG-HSZT (Deutsche Arbeitsgemeinschaft für Hämatopoetische Stammzelltransplantation und Zelluläre Therapie; German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy) performed a survey among 26 German CAR-T cell centers.

Results: We received answers from 17 centers (65%). The survey documents the relevance of evidence in the CAR-T cell field with a homogeneity of practice in areas with existing clinical evidence. In contrast, in areas with no - or low quality - clinical evidence, we identified significant variety in management in between the centers: management of cytokine release syndrome, immune effector cell-related neurotoxicity syndrome, IgG substitution, autologous stem cell backups, anti-infective prophylaxis, and vaccinations.

Conclusion: The results indicate the urgent need for better harmonization of supportive care in CAR-T cell therapies including clinical research to improve clinical outcome.

背景:CAR-T细胞治疗已成为非霍奇金淋巴瘤和多发性骨髓瘤等复发或难治性血液系统恶性肿瘤的标准疗法。由于CAR-T细胞治疗领域进展迅速,且缺乏公认的治疗指南,我们假设各中心在短期和长期并发症的预防、诊断和管理方面存在显著差异:为了了解德国各中心目前的 CAR-T 细胞管理情况,确定医疗需求和未来临床研究的具体领域,DAG-HSZT(德国造血干细胞移植和细胞疗法工作组)对德国 26 家 CAR-T 细胞中心进行了调查:我们收到了来自 17 个中心(65%)的答复。调查显示,CAR-T 细胞领域的证据具有相关性,在已有临床证据的地区,实践具有同质性。与此相反,在没有临床证据或临床证据质量较低的领域,我们发现各中心之间的管理存在显著差异:细胞因子释放综合征(CRS)、免疫效应细胞相关神经毒性综合征(ICANS)、IgG替代、自体干细胞备份、抗感染预防和疫苗接种的管理:结果表明,迫切需要更好地协调CAR-T细胞疗法中的支持性护理,包括临床研究,以改善临床结果。
{"title":"Management of Patients Undergoing CAR-T Cell Therapy in Germany.","authors":"Olaf Penack, Peter Dreger, Salem Ajib, Francis Ayuk, Ben-Niklas Baermann, Gesine Bug, Oliver Kriege, Madlen Jentzsch, Guido Kobbe, Christian Koenecke, Mathias Lutz, Sonja Martin, Paul-Gerhard Schlegel, Roland Schroers, Bastian von Tresckow, Vladan Vucinic, Marion Subklewe, Wolfgang Bethge, Daniel Wolff","doi":"10.1159/000536201","DOIUrl":"10.1159/000536201","url":null,"abstract":"<p><strong>Introduction: </strong>Chimeric antigen receptor positive T cell (CAR-T cell) treatment became standard therapy for relapsed or refractory hematologic malignancies, such as non-Hodgkin's lymphoma and multiple myeloma. Owing to the rapidly progressing field of CAR-T cell therapy and the lack of generally accepted treatment guidelines, we hypothesized significant differences between centers in the prevention, diagnosis, and management of short- and long-term complications.</p><p><strong>Methods: </strong>To capture the current CAR-T cell management among German centers to determine the medical need and specific areas for future clinical research, the DAG-HSZT (Deutsche Arbeitsgemeinschaft für Hämatopoetische Stammzelltransplantation und Zelluläre Therapie; German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy) performed a survey among 26 German CAR-T cell centers.</p><p><strong>Results: </strong>We received answers from 17 centers (65%). The survey documents the relevance of evidence in the CAR-T cell field with a homogeneity of practice in areas with existing clinical evidence. In contrast, in areas with no - or low quality - clinical evidence, we identified significant variety in management in between the centers: management of cytokine release syndrome, immune effector cell-related neurotoxicity syndrome, IgG substitution, autologous stem cell backups, anti-infective prophylaxis, and vaccinations.</p><p><strong>Conclusion: </strong>The results indicate the urgent need for better harmonization of supportive care in CAR-T cell therapies including clinical research to improve clinical outcome.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139417749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians. 与同种异体干细胞移植相关的持续医学教育的障碍和促进因素--对医生的定性研究。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-01-24 DOI: 10.1159/000536429
Sascha Eickmann, Daniel Wolff, Guido Kobbe, Peter Dreger, Nicolaus Kröger, Anne Herrmann-Johns

Introduction: This study explored qualitatively, in a sample of German hematologists working in clinical allogeneic hematopoietic stem cell transplantation (alloHSCT), perceptions of barriers and facilitators to participate in continuous medical education (CME), to provide detailed information on how to improve participation in CME activities related to alloHSCT, which may also be applicable to other areas of medicine.

Methods: Based on a recruitment campaign of the German Association for Hematopoietic Stem Cell Transplantation (DAG-HSZT), 21 semi-structured telephone interviews were conducted, transcribed, and analyzed using framework analysis.

Results: Three clusters of barriers were identified that explain why alloHSCT physicians may or may not participate in CME: individual constraints (e.g., better networking, young physicians being overwhelmed by the complexity of alloHSCT), structural constraints (e.g., time and financial issues, tailoring CME courses according to the targeted audience), and content-related constraints (e.g., requirement of CME sessions, provision of an overview of CME courses, more flexible offers). We discuss the ten most frequently raised issues, including the use of incentives and the need for support at the start of residency, staff shortages, and requirements for learning sessions.

Conclusion: There is a need for a paradigm shift in CME related to alloHSCT toward a more individualized and needs-based approach. Close monitoring of residents' needs and learning progress, as well as feedback systems, could help identify appropriate CME courses that should be integrated into a tiered learning system. CME should be more targeted to specific audiences (i.e., residents, fellows, and attendees) to provide training that is tailored to individual CME needs. On-demand courses can help balance work and family obligations. Finally, peer-reviewed, up-to-date information platforms should be expanded.

研究背景 本研究以德国从事临床异基因造血干细胞移植(alloHSCT)的血液学专家为样本,定性地探讨了他们对参与继续医学教育(CME)的障碍和促进因素的看法,从而提供了如何提高参与与alloHSCT相关的继续医学教育活动的详细信息,这些信息可能也适用于其他医学领域。方法 根据德国造血干细胞移植协会(DAG-HSZT)的一次招募活动,进行了 21 次半结构式电话访谈,将访谈内容转录并使用框架分析法进行分析。结果 确定了三类障碍,解释了异体造血干细胞移植医师为何可能参加或可能不参加继续医学教育:个人制约因素(如更好的人际关系网络、年轻医师被异体造血干细胞移植的复杂性压垮)、结构性制约因素(如时间和经济问题、根据目标受众量身定制继续医学教育课程)以及与内容相关的制约因素(如对继续医学教育课程的要求、提供继续医学教育课程概览、提供更灵活的课程)。我们讨论了十个最常见的问题,包括使用激励措施和在住院医师培训开始时提供支持的必要性、人员短缺以及对学习课程的要求。结论 与异体母细胞移植相关的继续医学教育需要转变模式,采用更加个性化和以需求为基础的方法。密切关注住院医师的需求和学习进度以及反馈系统有助于确定合适的继续医学教育课程,并将其纳入阶梯式学习系统。继续医学教育应更密切地关注特定的目标人群(即住院医师、研究员和与会者),提供适合个人需要的继续医学教育培训。点播课程可能有助于在工作和家庭义务之间取得平衡。最后,应扩大经同行评审的最新信息平台。
{"title":"Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians.","authors":"Sascha Eickmann, Daniel Wolff, Guido Kobbe, Peter Dreger, Nicolaus Kröger, Anne Herrmann-Johns","doi":"10.1159/000536429","DOIUrl":"10.1159/000536429","url":null,"abstract":"<p><strong>Introduction: </strong>This study explored qualitatively, in a sample of German hematologists working in clinical allogeneic hematopoietic stem cell transplantation (alloHSCT), perceptions of barriers and facilitators to participate in continuous medical education (CME), to provide detailed information on how to improve participation in CME activities related to alloHSCT, which may also be applicable to other areas of medicine.</p><p><strong>Methods: </strong>Based on a recruitment campaign of the German Association for Hematopoietic Stem Cell Transplantation (DAG-HSZT), 21 semi-structured telephone interviews were conducted, transcribed, and analyzed using framework analysis.</p><p><strong>Results: </strong>Three clusters of barriers were identified that explain why alloHSCT physicians may or may not participate in CME: individual constraints (e.g., better networking, young physicians being overwhelmed by the complexity of alloHSCT), structural constraints (e.g., time and financial issues, tailoring CME courses according to the targeted audience), and content-related constraints (e.g., requirement of CME sessions, provision of an overview of CME courses, more flexible offers). We discuss the ten most frequently raised issues, including the use of incentives and the need for support at the start of residency, staff shortages, and requirements for learning sessions.</p><p><strong>Conclusion: </strong>There is a need for a paradigm shift in CME related to alloHSCT toward a more individualized and needs-based approach. Close monitoring of residents' needs and learning progress, as well as feedback systems, could help identify appropriate CME courses that should be integrated into a tiered learning system. CME should be more targeted to specific audiences (i.e., residents, fellows, and attendees) to provide training that is tailored to individual CME needs. On-demand courses can help balance work and family obligations. Finally, peer-reviewed, up-to-date information platforms should be expanded.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10997258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report. 激光间质热疗治疗大丘脑胶质瘤并获得长期缓解:病例报告。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2023-12-26 DOI: 10.1159/000535991
Alexander Hoyningen, Kira-Lee Koster, Marian C Neidert, Oliver Bozinov, Arno Lauber, Olaf Chan-Hi Kim, Thomas Hundsberger, Marie T Krüger

Introduction: Thalamic gliomas pose a particular therapeutic challenge as complete resection is rarely achieved due to the deep and eloquent location. Laser interstitial thermal therapy (LITT) may provide a valuable management option for deep-seated gliomas that are not accessible with open surgery.

Case presentation: A 57-year-old woman presented with a rapidly progressive large thalamic glioblastoma. Opting for full ablation, we selected a challenging trajectory to maximize the possibility of full ablation. At 2.4 cm in diameter, the tumour was larger than recommended for LITT; nevertheless, three laser ablations along a single trajectory resulted in macroscopic ablation without complications. Adjuvant radio-chemotherapy was started soon after surgery without radiological recurrence 1.5 years after the initial surgery.

Conclusion: This case demonstrates the potential when thalamic tumours are managed with timely LITT treatment and meticulous trajectory planning. Moreover, it highlights the need for close interdisciplinary management with neurosurgeons, neuropathologists, neuroradiologists, and neurooncologists.

简介丘脑胶质瘤是一种特殊的治疗难题,因为其位置深且视野清晰,很少能实现完全切除。激光间质热疗(LITT)可为开放性手术无法切除的深部胶质瘤提供有价值的治疗方案:病例介绍:一名 57 岁的女性患有进展迅速的丘脑大胶质母细胞瘤。为了最大限度地实现完全消融,我们选择了一个具有挑战性的手术路径。肿瘤直径为 2.4 厘米,比建议的 LITT 更大;尽管如此,沿单一轨迹进行的三次激光消融术均实现了大面积消融,且未出现并发症。术后很快就开始了辅助放射化疗,在首次手术 1.5 年后未出现放射性复发:本病例展示了丘脑肿瘤通过及时的 LITT 治疗和精心的轨迹规划所具有的潜力。此外,该病例还强调了与神经外科医生、神经病理学家、神经放射学家和神经肿瘤学家进行密切的跨学科管理的必要性。
{"title":"Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report.","authors":"Alexander Hoyningen, Kira-Lee Koster, Marian C Neidert, Oliver Bozinov, Arno Lauber, Olaf Chan-Hi Kim, Thomas Hundsberger, Marie T Krüger","doi":"10.1159/000535991","DOIUrl":"10.1159/000535991","url":null,"abstract":"<p><strong>Introduction: </strong>Thalamic gliomas pose a particular therapeutic challenge as complete resection is rarely achieved due to the deep and eloquent location. Laser interstitial thermal therapy (LITT) may provide a valuable management option for deep-seated gliomas that are not accessible with open surgery.</p><p><strong>Case presentation: </strong>A 57-year-old woman presented with a rapidly progressive large thalamic glioblastoma. Opting for full ablation, we selected a challenging trajectory to maximize the possibility of full ablation. At 2.4 cm in diameter, the tumour was larger than recommended for LITT; nevertheless, three laser ablations along a single trajectory resulted in macroscopic ablation without complications. Adjuvant radio-chemotherapy was started soon after surgery without radiological recurrence 1.5 years after the initial surgery.</p><p><strong>Conclusion: </strong>This case demonstrates the potential when thalamic tumours are managed with timely LITT treatment and meticulous trajectory planning. Moreover, it highlights the need for close interdisciplinary management with neurosurgeons, neuropathologists, neuroradiologists, and neurooncologists.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139040330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review. 饮食因素与皮肤黑色素瘤的关系:希腊病例对照研究及文献综述。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-03-12 DOI: 10.1159/000538278
Andreas Katsimpris, Antonios G Antoniadis, Nick Dessypris, Konstantinos Karampinos, Helen J Gogas, Eleni T Petridou

Introduction: It has been postulated that nutrition may influence the risk for cutaneous melanoma (CM); therefore, we aimed to assess the associations of food groups and individual nutrient intakes with CM in a Greek population.

Methods: In this case-control study, 151 patients with histologically confirmed CM, newly diagnosed and treated in the Oncology Department of the "Laikon" University Hospital (Athens, Greece), and 151 age- and sex-matched healthy individuals residing in the Athens metropolitan area, recruited among participants for routine health examinations, were included. All participants completed a questionnaire comprising anthropometric measurements, sociodemographic, lifestyle, and health-related variables. A validated, semiquantitative food frequency questionnaire was used to assess average consumption of 136 food items during the 12 months preceding the onset of disease. Multivariate conditional regression models were used to derive odds ratios (ORs) with 95% confidence intervals (95% CI) regarding the association of nine food groups and seven macronutrients with CM.

Results: Statistically significant positive associations with CM were found with higher energy intake (OR: 1.67, 95% CI: 1.22-2.30) and intake of saturated fatty acids (OR: 2.28, 95% CI: 1.00-5.28), after adjusting for sun sensitivity, major depression history, and alcohol intake. Inverse associations with higher intake of milk and dairy products (OR: 0.65, 95% CI: 0.48-0.88), fruits (OR: 0.68, 95% CI: 0.51-0.90), added lipids (OR: 0.65, 95% CI: 0.47-0.91), and sugars and syrups (OR: 0.70, 95% CI: 0.53-0.93) were also observed.

Conclusions: Beyond intrinsic risk factors, our results support associations of CM with multiple food groups and nutrients; if confirmed by prospective studies, these findings can add further knowledge about this fatal cancer.

简介:营养可能会影响皮肤黑色素瘤(CM)的发病风险:据推测,营养可能会影响皮肤黑色素瘤(CM)的发病风险;因此,我们旨在评估希腊人群中食物种类和单项营养素摄入量与CM的相关性:在这项病例对照研究中,我们纳入了 151 名组织学确诊的皮肤黑色素瘤患者,他们都是在希腊雅典 "Laikon "大学医院肿瘤科接受治疗的新确诊患者;同时还纳入了 151 名年龄和性别相匹配的健康人,他们都居住在雅典大都会地区,是在常规健康检查参与者中招募的。所有参与者都填写了一份问卷,内容包括人体测量、社会人口学、生活方式和健康相关变量。他们还使用了一份经过验证的半定量食物频率问卷,以评估发病前 12 个月内 136 种食物的平均消耗量。采用多变量条件回归模型得出了九类食物和七种宏量营养素与中医的几率比(ORs)及 95% 置信区间(95% CI):在对阳光敏感性、重度抑郁症病史和酒精摄入量进行调整后,发现能量摄入量越高(OR:1.67,95% CI:1.22-2.30),饱和脂肪酸摄入量越高(OR:2.28,95% CI:1.00-5.28),与中风呈统计学意义上的正相关。此外,还观察到与牛奶和乳制品(OR:0.65,95% CI:0.48-0.88)、水果(OR:0.68,95% CI:0.51-0.90)、添加脂质(OR:0.65,95% CI:0.47-0.91)以及糖和糖浆(OR:0.70,95% CI:0.53-0.93)摄入量较高呈反向关系:除了内在的风险因素外,我们的研究结果还支持中医与多种食物组和营养素的关联;如果得到前瞻性研究的证实,这些发现将为这一致命癌症增添更多的知识。
{"title":"Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review.","authors":"Andreas Katsimpris, Antonios G Antoniadis, Nick Dessypris, Konstantinos Karampinos, Helen J Gogas, Eleni T Petridou","doi":"10.1159/000538278","DOIUrl":"10.1159/000538278","url":null,"abstract":"<p><strong>Introduction: </strong>It has been postulated that nutrition may influence the risk for cutaneous melanoma (CM); therefore, we aimed to assess the associations of food groups and individual nutrient intakes with CM in a Greek population.</p><p><strong>Methods: </strong>In this case-control study, 151 patients with histologically confirmed CM, newly diagnosed and treated in the Oncology Department of the \"Laikon\" University Hospital (Athens, Greece), and 151 age- and sex-matched healthy individuals residing in the Athens metropolitan area, recruited among participants for routine health examinations, were included. All participants completed a questionnaire comprising anthropometric measurements, sociodemographic, lifestyle, and health-related variables. A validated, semiquantitative food frequency questionnaire was used to assess average consumption of 136 food items during the 12 months preceding the onset of disease. Multivariate conditional regression models were used to derive odds ratios (ORs) with 95% confidence intervals (95% CI) regarding the association of nine food groups and seven macronutrients with CM.</p><p><strong>Results: </strong>Statistically significant positive associations with CM were found with higher energy intake (OR: 1.67, 95% CI: 1.22-2.30) and intake of saturated fatty acids (OR: 2.28, 95% CI: 1.00-5.28), after adjusting for sun sensitivity, major depression history, and alcohol intake. Inverse associations with higher intake of milk and dairy products (OR: 0.65, 95% CI: 0.48-0.88), fruits (OR: 0.68, 95% CI: 0.51-0.90), added lipids (OR: 0.65, 95% CI: 0.47-0.91), and sugars and syrups (OR: 0.70, 95% CI: 0.53-0.93) were also observed.</p><p><strong>Conclusions: </strong>Beyond intrinsic risk factors, our results support associations of CM with multiple food groups and nutrients; if confirmed by prospective studies, these findings can add further knowledge about this fatal cancer.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11078323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023. 欧洲肿瘤内科学会 2023 年年会的胰腺、肝脏和胆道肿瘤学亮点。
IF 2 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 Epub Date: 2024-02-22 DOI: 10.1159/000537935
Christian Heise, Alexander Edward Nieto, Magdalena K Scheck, Ira Ekmekciu, Greta Sommerhäuser, Anke Reinacher-Schick, Ralf-Dieter Hofheinz, Sylvie Lorenzen, Henning Wege, Volker Kunzmann, Thorsten Oliver Götze, Ilektra Antonia Mavroeidi
{"title":"Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.","authors":"Christian Heise, Alexander Edward Nieto, Magdalena K Scheck, Ira Ekmekciu, Greta Sommerhäuser, Anke Reinacher-Schick, Ralf-Dieter Hofheinz, Sylvie Lorenzen, Henning Wege, Volker Kunzmann, Thorsten Oliver Götze, Ilektra Antonia Mavroeidi","doi":"10.1159/000537935","DOIUrl":"10.1159/000537935","url":null,"abstract":"","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139932279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells. 犬瘟热病毒在人导管乳腺癌细胞中的溶瘤活性。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-26 DOI: 10.1159/000535418
Dhwani Jhala, Neelam Nathani, Madhvi Joshi, Amrutlal Patel, Chaitanya G Joshi

Introduction: Oncolytic virotherapy is a novel strategy for cancer treatment in humans and companion animals. Canine distemper virus (CDV) is known to induce apoptosis in tumor cells, thus serving as a potential candidate for oncolytic therapy. However, the mechanism of viral oncolytic activity is less studied and varies depending on the type of cancer and cell lines.

Methods: In the present study, the susceptibility of the MCF-7 cell line to CDV infection was assessed using the CDV strain, which was confirmed previously through sequence analysis in the Vero cell line. The impact of CDV infection on cell proliferation and apoptosis was studied by evaluating the expression of four target genes including the myeloid cell leukemia 1 (MCL-1), phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), transcription factor (SP1), and DNA (cytosine-5)-methyltransferase 3A (DNMT3A).

Results: CDV replication in the cells induced cytopathic effect and decreased in the cell proliferation rates compared to the uninfected control. MCL-1, SP1, and PIK3R1 gene expression was down-regulated, while the expression of DNMT3A was up-regulated 3 days post-infection. The expression levels of the target genes suggest that CDV may be inducing the intrinsic apoptotic pathway in the cancer cell line.

Conclusion: Overall, the results strongly propose CDV strain as a potential candidate for cancer therapy after detailed studies.

溶瘤病毒疗法是一种治疗人类和伴侣动物癌症的新策略。已知犬瘟热病毒(CDV)可诱导肿瘤细胞凋亡,因此可作为溶瘤治疗的潜在候选者。然而,病毒溶瘤活性的机制研究较少,并根据癌症和细胞系的类型而变化。在本研究中,MCF-7细胞系对CDV感染的易感性评估使用CDV菌株,该菌株先前通过Vero细胞系的序列分析证实。通过检测骨髓细胞白血病1 (MCL-1)、磷酸肌醇-3-激酶调控亚基1 (PIK3R1)、转录因子(SP1)和DNA(胞嘧啶-5)-甲基转移酶3A (DNMT3A) 4个靶基因的表达,研究CDV感染对细胞增殖和凋亡的影响。与未感染的对照组相比,CDV在细胞中的复制诱导了细胞病变效应,细胞增殖率下降。MCL-1、SP1和PIK3R1基因表达下调,DNMT3A基因表达上调。靶基因的表达水平提示CDV可能诱导了癌细胞固有的凋亡途径。总的来说,经过详细的研究,结果强烈建议犬瘟热病毒(CDV)毒株作为癌症治疗的潜在候选者。
{"title":"Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells.","authors":"Dhwani Jhala, Neelam Nathani, Madhvi Joshi, Amrutlal Patel, Chaitanya G Joshi","doi":"10.1159/000535418","DOIUrl":"10.1159/000535418","url":null,"abstract":"<p><strong>Introduction: </strong>Oncolytic virotherapy is a novel strategy for cancer treatment in humans and companion animals. Canine distemper virus (CDV) is known to induce apoptosis in tumor cells, thus serving as a potential candidate for oncolytic therapy. However, the mechanism of viral oncolytic activity is less studied and varies depending on the type of cancer and cell lines.</p><p><strong>Methods: </strong>In the present study, the susceptibility of the MCF-7 cell line to CDV infection was assessed using the CDV strain, which was confirmed previously through sequence analysis in the Vero cell line. The impact of CDV infection on cell proliferation and apoptosis was studied by evaluating the expression of four target genes including the myeloid cell leukemia 1 (MCL-1), phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1), transcription factor (SP1), and DNA (cytosine-5)-methyltransferase 3A (DNMT3A).</p><p><strong>Results: </strong>CDV replication in the cells induced cytopathic effect and decreased in the cell proliferation rates compared to the uninfected control. MCL-1, SP1, and PIK3R1 gene expression was down-regulated, while the expression of DNMT3A was up-regulated 3 days post-infection. The expression levels of the target genes suggest that CDV may be inducing the intrinsic apoptotic pathway in the cancer cell line.</p><p><strong>Conclusion: </strong>Overall, the results strongly propose CDV strain as a potential candidate for cancer therapy after detailed studies.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138441061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management and System Therapy of the Most Giant Known Malignant Metastatic Breast Phyllodes Tumor: A Case Report and Review of the Literature. 已知最巨大的恶性转移性乳腺梭形细胞瘤的手术治疗和系统疗法:病例报告和文献综述。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-02-21 DOI: 10.1159/000537956
Christina Kaiser, Alina-Valik Abramian, Andree Faridi

Introduction: Phyllodes tumors belong to uncommon fibroepithelial breast tumors with a range of biological behaviors. Phyllodes tumors are responsible for less than 1 percent of all neoplasms of the breast.

Case presentation: A 66-year-old woman presented to our Breastcancer Unit in March 2021 because of a huge mass of her left breast with bleeding out of a tumor necrosis. Five years ago in 2016, a benign phyllodes tumor was diagnosed externally. When we started the treatment, the tumor had a weight of 18.6 kg.

Conclusion: We describe the surgical management and the systemic treatment of metastatic disease.

皮样瘤属于不常见的乳腺纤维上皮性肿瘤,具有多种生物学行为。在所有乳腺肿瘤中,蝶形花瘤的发病率不到 1%。2021 年 3 月,一位 66 岁的妇女因左侧乳房巨大肿块伴肿瘤坏死出血来我院乳腺癌科就诊。五年前的 2016 年,她被诊断出患有良性乳腺肿瘤。我们开始治疗时,肿瘤重达 18.6 公斤。我们描述了转移性疾病的手术治疗和全身治疗。
{"title":"Surgical Management and System Therapy of the Most Giant Known Malignant Metastatic Breast Phyllodes Tumor: A Case Report and Review of the Literature.","authors":"Christina Kaiser, Alina-Valik Abramian, Andree Faridi","doi":"10.1159/000537956","DOIUrl":"10.1159/000537956","url":null,"abstract":"<p><strong>Introduction: </strong>Phyllodes tumors belong to uncommon fibroepithelial breast tumors with a range of biological behaviors. Phyllodes tumors are responsible for less than 1 percent of all neoplasms of the breast.</p><p><strong>Case presentation: </strong>A 66-year-old woman presented to our Breastcancer Unit in March 2021 because of a huge mass of her left breast with bleeding out of a tumor necrosis. Five years ago in 2016, a benign phyllodes tumor was diagnosed externally. When we started the treatment, the tumor had a weight of 18.6 kg.</p><p><strong>Conclusion: </strong>We describe the surgical management and the systemic treatment of metastatic disease.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139932280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement. 巴伐利亚州的肿瘤心理自助小组:现状与改进建议。
IF 2.4 4区 医学 Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-03-08 DOI: 10.1159/000538248
Marietta Lieb, Martina Madl, Martin Vogelhuber, Matthias W Beckmann, Yesim Erim

Background: Self-help groups (SHGs) are an important cornerstone of the German health care system. Especially collaborations of SHGs with cancer centers enable active patient involvement in cancer care. We investigated the current situation and unmet needs of Bavarian SHGs in order to point out possible options of action.

Methods: We conducted a cross-sectional study with Bavarian psycho-oncological SHGs. Via e-mail, an online survey was sent to 150 SHGs registered at the BZKF (Bavarian Cancer Research Center). We assessed activities and needs of the SHGs as well as the nature of collaborations with cancer centers. We focused on adaptations during the COVID-19 pandemic and the inclusion of migrants.

Results: 46 (33.66%) SHGs participated, while 39 (84.78%) completed the questionnaire. During the COVID-19 pandemic, 50% of the SHGs reported less meetings. 22.7% changed to online meetings or other formats (43.2%). 20.9% of the SHGs had regular meetings with the cancer center, and 23.1% with the psycho-oncology. 51.2% evaluated the psycho-oncological services as neutral to dissatisfying due to lack of information, availability, and long waiting times. The SHGs indicated needs concerning interventions (coping strategies, digital applications, etc.), information, and better communication. Efforts for overcoming inequalities seemed rare: only 13.6% of the SHGs and 16.2% of the cancer centers had services for migrants.

Conclusions: This study gave an overview of current activities and needs of Bavarian SHGs. The implementation of patient guides, comprehensive information material, and low-threshold psycho-oncological services should be objectives in future care to increase patient satisfaction. The needs for services for migrants should be investigated in more detail.

背景:自助小组(SHGs)是德国医疗保健系统的重要基石。特别是自助团体与癌症中心的合作使患者能够积极参与癌症治疗。我们调查了巴伐利亚州自助团体的现状和未满足的需求,以指出可能的行动方案:我们对巴伐利亚肿瘤心理自助团体进行了横向研究。我们通过电子邮件向在巴伐利亚癌症研究中心(BZKF)注册的 150 个自助团体发送了在线调查问卷。我们对自助团体的活动和需求以及与癌症中心合作的性质进行了评估。我们重点关注了在 COVID-19 大流行期间的适应情况以及将移民纳入其中的情况:46个(33.66%)自助团体参加了调查,36个(24%)完成了问卷。在 COVID-19 大流行期间,50% 的自助团体减少了会议。22.7% 的小组改用了在线会议或其他形式(43.2%)。20.9% 的自助团体与癌症中心定期举行会议,23.1% 与肿瘤心理科定期举行会议。由于缺乏信息、可用性和等待时间长,51.2% 的人对肿瘤心理服务的评价为中性或不满意。自助团体表示需要干预措施(应对策略、数字应用程序等)、信息和更好的沟通。为克服不平等所做的努力似乎很少:只有 13.6% 的自助团体和 16.2% 的癌症中心为移民提供服务:本研究概述了巴伐利亚自助团体目前的活动和需求。为提高患者满意度,今后的治疗目标应包括实施患者指南、提供全面的信息资料和低门槛的肿瘤心理服务。此外,还应对移民的服务需求进行更详细的调查。
{"title":"Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement.","authors":"Marietta Lieb, Martina Madl, Martin Vogelhuber, Matthias W Beckmann, Yesim Erim","doi":"10.1159/000538248","DOIUrl":"10.1159/000538248","url":null,"abstract":"<p><strong>Background: </strong>Self-help groups (SHGs) are an important cornerstone of the German health care system. Especially collaborations of SHGs with cancer centers enable active patient involvement in cancer care. We investigated the current situation and unmet needs of Bavarian SHGs in order to point out possible options of action.</p><p><strong>Methods: </strong>We conducted a cross-sectional study with Bavarian psycho-oncological SHGs. Via e-mail, an online survey was sent to 150 SHGs registered at the BZKF (Bavarian Cancer Research Center). We assessed activities and needs of the SHGs as well as the nature of collaborations with cancer centers. We focused on adaptations during the COVID-19 pandemic and the inclusion of migrants.</p><p><strong>Results: </strong>46 (33.66%) SHGs participated, while 39 (84.78%) completed the questionnaire. During the COVID-19 pandemic, 50% of the SHGs reported less meetings. 22.7% changed to online meetings or other formats (43.2%). 20.9% of the SHGs had regular meetings with the cancer center, and 23.1% with the psycho-oncology. 51.2% evaluated the psycho-oncological services as neutral to dissatisfying due to lack of information, availability, and long waiting times. The SHGs indicated needs concerning interventions (coping strategies, digital applications, etc.), information, and better communication. Efforts for overcoming inequalities seemed rare: only 13.6% of the SHGs and 16.2% of the cancer centers had services for migrants.</p><p><strong>Conclusions: </strong>This study gave an overview of current activities and needs of Bavarian SHGs. The implementation of patient guides, comprehensive information material, and low-threshold psycho-oncological services should be objectives in future care to increase patient satisfaction. The needs for services for migrants should be investigated in more detail.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140094452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oncology Research and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1